Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Renasant Corporation (RNST)

40,83

0,29

(0,72%)

Fermé 07 Juin 10:00PM

40,83

0,00

(0,00%)

Après les heures de négociation: 1:59AM

Renasant Corporation ([symbol]) Options

RNST Flux des options

Achats

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
17,50	21,50	24,60	22,81	23,05	0,00	0,00 %	0	1	-
20,00	19,00	22,10	20,36	20,55	0,00	0,00 %	0	2	-
22,50	16,50	19,60	18,65	18,05	-0,00	0,00 %	0	0	-
25,00	15,50	17,00	15,81	16,25	0,41	2,66 %	2	1	05/6/2026
30,00	9,00	12,10	0,00	10,55	0,00	0,00 %	0	0	-
35,00	5,70	7,00	6,12	6,35	1,35	28,30 %	2	0	05/6/2026
40,00	0,75	3,30	1,00	2,025	0,00	0,00 %	0	1 084	-
45,00	0,00	1,00	1,20	1,20	0,00	0,00 %	0	0	-
50,00	0,00	2,15	0,00	0,00	0,00	0,00 %	0	0	-
55,00	0,00	2,15	0,00	0,00	0,00	0,00 %	0	0	-

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Ventes

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
17,50	0,00	2,15	0,00	0,00	0,00	0,00 %	0	0	-
20,00	0,00	2,15	0,00	0,00	0,00	0,00 %	0	0	-
22,50	0,00	2,15	0,00	0,00	0,00	0,00 %	0	0	-
25,00	0,00	0,20	0,00	0,00	0,00	0,00 %	0	0	-
30,00	0,00	2,15	0,00	0,00	0,00	0,00 %	0	0	-
35,00	0,10	0,25	0,75	0,175	0,00	0,00 %	0	2	-
40,00	0,00	2,95	1,25	1,25	0,00	0,00 %	0	4	-
45,00	2,70	6,30	0,00	4,50	0,00	0,00 %	0	0	-
50,00	8,00	11,30	0,00	9,65	0,00	0,00 %	0	0	-
55,00	12,80	16,20	0,00	14,50	0,00	0,00 %	0	0	-

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
SCAGScage Future	US$ 0,8489 (196,61%)	92,75M
SPHLSpringview Holdings Ltd	US$ 5,38 (125,20%)	40,61M
NOTVInotiv Inc	US$ 0,1638 (89,15%)	1,07B
RMSGReal Messenger Corporation	US$ 1,809 (64,45%)	199,97M
STISolidion Technology Inc	US$ 35,50 (56,32%)	38,55M
NUWENewellis Inc	US$ 0,1625 (-62,30%)	50M
NYXHNyxoah SA	US$ 1,41 (-51,04%)	2,47M
CYPHCypherpunk Technologies Inc	US$ 0,5176 (-47,26%)	30,53M
TDICDreamland Ltd	US$ 0,2277 (-37,68%)	12,09M
FOFOHang Feng Technology Innovation Co Ltd	US$ 3,91 (-36,73%)	381,9k
NOTVInotiv Inc	US$ 0,1638 (89,15%)	1,07B
SNBRSleep Number Corporation	US$ 0,477 (36,25%)	305,13M
SMTKSmartKem Inc	US$ 0,419101 (30,97%)	232,19M
NVDANVIDIA Corporation	US$ 205,10 (-6,20%)	220,65M
RMSGReal Messenger Corporation	US$ 1,809 (64,45%)	199,97M

jour_trader

jour_trader il y a 5 minutes

1.5-2B, but I would expect it to grow over time as well. Perhaps grows into $2.5B? No idea, but pricing pressures will be unlike anything we have seen before.

meixatech

meixatech il y a 6 minutes

Folks,
IMO it is apparent to me that a major physiological benefit of some ampakines is the potential synergistic effect of combining with other bioactive molecules. Question posed to Google AI:

Would the molecules of the Neuroscience Research Group, Danube Neuroscience Resear

GoonOfWallSt

GoonOfWallSt il y a 7 minutes

It's oddly quiet from the pumpsh!ts squad side. Did they all take a vacation for the whole month of June to celebrate their pride?

chemist72

chemist72 il y a 8 minutes

For some reason (which I don't understand), the Copilot links give different responses each time I click on them.
THEREFORE, PLEASE TAKE THESE RESULTS WITH CAUTION!! lol

janetcanada

janetcanada il y a 9 minutes

🙌*** VSMT....& Positive Resumé From "Analyst Stock Titan"....
***https://www.stocktitan.net › news

☯️***From Barchart.....
***https://www.barchart.com/stocks/quotes/VMST/overview

chemist72

chemist72 il y a 13 minutes

Revised Copilot answer. LOL
https://www.bing.com/search?q=What+kind+of+growth+rate+is+required+to+go+from+%245M+in+revenues+to+%241B+in+revenues+over+3+years%2C+5+years+and+10+years%3F&form=ANNTH1&refig=6a25673c262b486cbd9f21ba447dd311&pc=EDGEDSE&adppc=EDGEBRV

M1Maggot

M1Maggot il y a 14 minutes

I don't really care if they announce that they are selling the dirt on the property for topsoil but these clowns better come out with something that generates income or this stock will hit new lows and SOON !!!!!

jour_trader

jour_trader il y a 14 minutes

Love seeing the movement on the Oxy patent dispute. We’ll still be held up by FDA even if case is dismissed.

upper11

upper11 il y a 16 minutes

77 19 24 11 Tia

meixatech

meixatech il y a 18 minutes

The Neuroscience Research Group, Danube Neuroscience Research Laboratory focuses on the kynurenine pathway. According to AI:

The kynurenine pathway (KP) is the primary metabolic route for the essential amino acid tryptophan. It connects the immune, metabolic, and nervous syst

Golden Cross

Golden Cross il y a 20 minutes

$ILLR 🗞️ Eight Sports Capital Secures Major Enic Stake
🔗 https://www.goal.com/en-gh/lists/tottenham-daniel-levy-sells-35-percent-enic-stake-eight-sports-capital/bltada9f5dccfa90152

(Triller $ILLR owns Eight Sports Capital)

✨ A new e

Golden Cross

Golden Cross il y a 20 minutes

$ILLR 🗞️ Eight Sports Capital Secures Major Enic Stake
🔗 https://www.goal.com/en-gh/lists/tottenham-daniel-levy-sells-35-percent-enic-stake-eight-sports-capital/bltada9f5dccfa90152

(Triller $ILLR owns Eight Sports Capital)

✨ A new e

1kgwxman

1kgwxman il y a 21 minutes

Sticks and stones...sticks and stones.
Smart investors ignore the "noise" and go about their lives.
Nobody controls or influences their investment decisions except themselves.
Anonymous attacks on specific stocks like AMFN are irrelevant and impotent, as are those against invest

Eagle1

Eagle1 il y a 22 minutes

Good Morning and Yes indeed SDCRBS, Great to see you here!

jimr1717

jimr1717 il y a 23 minutes

Bingo! It’s all a ruse! There is nothing here other than shares to dump on marks.

FrostyIsland3

FrostyIsland3 il y a 23 minutes

I read the article and have sympathy for the guy, but the article does not go into his treatment for GBM. He strikes me as the sort of person who has the wealth to afford DCVax-L and I hope he is trying this treatment because it will probably lengthen his life.

jour_trader

jour_trader il y a 24 minutes

Today’s US market value is about $8B. So if you take 20% (go generic) of that you’re at $1.6B. Take another 20% of that for Elite’s potential market share, but again only about half (take 50% of that) would show up as revenue in our P&L due to splits. Quick back of envelope math gives me about $200M

chemist72

chemist72 il y a 25 minutes

Please draw your own conclusions.
I'm not trying to push one narrative over another.

trunkmonk

trunkmonk il y a 28 minutes

now why would i base my financial decisions on a nobody in a utube vid? waste of time.

Big Hook

Big Hook il y a 29 minutes

How do you make money on app no one knows about.? Think about that. No advertising or marketing as of now.

georgejjl

georgejjl il y a 32 minutes

‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid

https://www.cnbc.com/amp/2026/06/04/biotech-ma-dealmaking-pharma-106-billion.html

Good luck and GOD bless,

Sammy boy

Sammy boy il y a 33 minutes

Another Christmas nearing ! Hard to believe, all talk no action ! The ECONOMY SUCKS don’t kid yourself !

sage007

sage007 il y a 34 minutes

Even if your assumptions about cancer numbers proved to be correct, one major issue is execution to perfection. I don’t really have confidence in this management to do so. Nevertheless, I do hope you are proven correct. I wouldn’t build any rosy expectations based on these assumptions of yours.

Oxford Nutrascience

Fairlead Tactical Sector...

Innovator Power Buffer S...

Herzfeld Caribbean Basin

Intelligent Systems

First Industrial Realty

Vanguard Long Term

Innovator Emerging Marke...

RBC Short Term US Corpor...

WisdomTree International...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.